Four new platinum(II) complexes of general formula [PtCl2(R2-S,S-eddtyr)] (R = ethyl, n-propyl, n-butyl and n-pentyl); S,S-eddtyr = ethylenediamine-N,N′-di-(2,2′-di(4-hydroxy)-benzyl-acetic acid) have been synthesized and characterized by microanalysis, and infrared, 1H NMR and 13C NMR spectroscopy. The in vitro antimicrobial activity of ligands L1–L4 [L = R2-S,S-eddtyr; R = ethyl (L1), n-propyl (L2), n-butyl (L3), n-pentyl (L4)], platinum(II) complexes C1–C4 [PtCl2(R2-S,S-eddtyr)] [R = ethyl (C1), n-propyl (C2), n-butyl (C3), n-pentyl (C4)] and palladium(II) complexes C5–C8 [PdCl2(R2-S,S-eddtyr)] [R = ethyl (C5), n-propyl (C6) or n-butyl (C7) or n-pentyl (C8)] was investigated. The cytotoxicity of ligands and platinum(II) complexes was investigated using MTT assay. The interaction of platinum and palladium complexes [MCl2(R2-S,S-eddtyr)] (M = Pt or Pd) with calf thymus DNA (CT-DNA) was investigated using UV-Vis absorption and fluorescence spectroscopy. The association constant (Kb) estimated from the absorption spectral study and the quenching constant (KSV) calculated from relevant fluorescence quenching data indicate a non-covalent interaction between the metal complex and DNA. Ethidium bromide (EB) competitive studies revealed that complexes C1–C8 could interact with CT-DNA through intercalation. Furthermore, the interactions between human serum albumin (HSA) and the platinum(II) and palladium(II) complexes were also investigated by UV-Vis absorption and fluorescence spectroscopy, showing that the new complexes could strongly bind with HSA.
The new coumarine derivate with methyl ester of 2-((Z)-1(2,4-dioxochroman-3-ylidene)ethylamino)-3-methylbutanoic acid and the corresponding palladium(II) complex are synthesized and characterized by microanalysis, infrared, 1H and 13C NMR spectroscopy. The proposed structure of the ligand was confirmed based on the X-ray structural study.
1 January 2018 in Srpski arhiv za celokupno lekarstvo
Introduction/Objective. The increasing resistance to macrolides and lincosamides among staphylococci and streptococci is becoming a global problem. The aim of this study was to investigate the prevalence of macrolide-lincosamide-streptogramin (MLS) resistance phenotypes in staphylococcal and streptococcal isolates in southeast Serbia. Methods. The MLS phenotypes were determined by the double-disk diffusion method in 2,121 inpatient and outpatient staphylococcal and streptococcal isolates collected during a one-year period at the Center for Microbiology. Results. The methicillin-resistant staphylococci isolates were significantly more resistant to penicillin, erythromycin, clindamycin, gentamicin, and ciprofloxacin (100%, 100%, 29.2%, 65.6%, and 53.1%, respectively) than the methicillin-sensitive ones (93.6%, 64.9%, 12%, 28.9%, and 11.7%, respectively). The inducible clindamycin resistance phenotype was dominant in S. aureus and coagulase-negative staphylococci isolates. S. pneumoniae, S. pyogenes, and S. agalactiae isolates showed very high resistance to erythromycin (77.8%, 46.2%, and 32.4%, respectively). All staphylococci and streptococci isolates were sensitive to vancomycin and linezolid, and all beta-hemolytic streptococci isolates to penicillin and ceftriaxone. Conclusion. The phenotypic triage of staphylococci is necessary in order to separate inducible resistant and truly clindamycin-sensitive isolates. Macrolides should not be recommended for empirical therapy of streptococcal infections. Penicillins remain the drug of choice for treatment of streptococcal infections in our local area.
1 January 2026 in Srpski arhiv za celokupno lekarstvo
Introduction/Objective. The escalating resistance of numerous pathogens to currently available therapeutic agents has sparked a renewed interest in the search of novel antimicrobial compounds. Plants have become a potentially valuable source of these compounds. This study aimed to assess the direct and indirect antimicrobial effects of Onosma visianii Clem root extract on reference and clinical bacterial strains using broth microdilution and a modified ethidium bromide/acridine orange (EB/AO) fluorescence assay. Methods. The ethanolic extract obtained from the dried root of Onosma visianii Clem was used to determine the minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs) by broth microdilution, as well as the half maximal inhibitory concentration ( \mathrm{IC_{50}} ) values for reference and clinical bacterial strains. The EB/AO fluorescence method was employed to assess the effect on efflux pumps in methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecalis (VRE), using 50% of the MIC value of the extract. Results. The MIC, MBC, and \mathrm{IC_{50}} values for Gram-positive bacteria were all below 15 μg/mL. The extract demonstrated strong antibacterial activity against VRE and, in particularly, against MRSA isolates (MIC = 7.81 μg/mL and MBC = 7.81 μg/mL). Furthermore, treatment with 50% of the MIC concentration produced a significant inhibitory effect on efflux pumps in Gram-positive bacteria, ranging from 18% to 26% compared with untreated cells. Conclusion. The root extract of Onosma visianii Clem exhibited antimicrobial activity against both Grampositive and Gram-negative bacteria, with particularly strong effects against VRE and MRSA. In addition, the observed inhibition of bacterial efflux pumps underscores its promise as a candidate for pharmacological evaluation of the antibiotic properties of the Onosma visianii Clem root extract.